{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:06:11Z","timestamp":1790233571420,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>\n            Endothelium-derived endothelin (ET)-1 has been implicated in the development of hypertension and end-organ damage, but its exact role remains unclear. We have shown that tamoxifen-inducible endothelium-restricted human ET-1 overexpressing (ieET-1) mice exhibited blood pressure rise after a 3-week induction in an ET type A (ET\n            <jats:sub>A<\/jats:sub>\n            ) receptor-dependent manner, in absence of vascular and renal injury. It is unknown whether long-term ET-1 overexpression results in sustained blood pressure elevation and vascular and renal injury. Adult male ieET-1 and control tamoxifen-inducible endothelium-restricted Cre recombinase (ieCre) mice were induced with tamoxifen and 2.5 months later, were treated with or without the ET\n            <jats:sub>A<\/jats:sub>\n            receptor blocker atrasentan for 2 weeks. Three-month induction of endothelial human ET-1 overexpression increased blood pressure (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01), reduced renal artery flow (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001), and caused mesenteric small artery stiffening (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05) and endothelial dysfunction (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01). These changes were accompanied by enhanced mesenteric small artery\n            <jats:italic>Col1A1<\/jats:italic>\n            and\n            <jats:italic>Col3A1<\/jats:italic>\n            expression, and perivascular adipose tissue oxidative stress (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05) and monocyte\/macrophage infiltration (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05). Early renal injury was demonstrated by increased kidney injury molecule-1 expression in renal cortex tubules (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05), with, however, undetectable lesions using histochemistry staining and unchanged urinary albumin. There was associated increased myeloid (CD11b\n            <jats:sup>+<\/jats:sup>\n            ) and myeloid-derived suppressive cell (CD11b\n            <jats:sup>+<\/jats:sup>\n            Gr-1\n            <jats:sup>+<\/jats:sup>\n            ) renal infiltration (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01) and greater frequency of myeloid and renal cells expressing the proinflammatory marker CD36 (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05). Atrasentan reversed or reduced all of the above changes (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05) except the endothelial dysfunction and collagen expression and reduced renal artery flow. These results demonstrate that long-term exposure to endothelial human ET-1 overexpression causes sustained blood pressure elevation and vascular and renal injury via ET\n            <jats:sub>A<\/jats:sub>\n            receptors.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.117.09925","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T10:05:13Z","timestamp":1510567513000},"page":"208-216","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":60,"title":["Three-Month Endothelial Human Endothelin-1 Overexpression Causes Blood Pressure Elevation and Vascular and Kidney Injury"],"prefix":"10.1161","volume":"71","author":[{"given":"Suellen C.","family":"Coelho","sequence":"first","affiliation":[{"name":"From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research (S.C.C., O.B., A.C., S.O., J.C.F.-A., T.B., P.P., E.L.S.), and Department of Medicine (E.L.S.), Sir Mortimer B. Davis\u2013Jewish General Hospital, McGill University, Montreal, Qu\u00e9bec, Canada; and Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse, Bad Nauheim, Germany (S.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Berillo","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research (S.C.C., O.B., A.C., S.O., J.C.F.-A., T.B., P.P., E.L.S.), and Department of Medicine (E.L.S.), Sir Mortimer B. Davis\u2013Jewish General Hospital, McGill University, Montreal, Qu\u00e9bec, Canada; and Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse, Bad Nauheim, Germany (S.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Caillon","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research (S.C.C., O.B., A.C., S.O., J.C.F.-A., T.B., P.P., E.L.S.), and Department of Medicine (E.L.S.), Sir Mortimer B. Davis\u2013Jewish General Hospital, McGill University, Montreal, Qu\u00e9bec, Canada; and Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse, Bad Nauheim, Germany (S.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiane","family":"Ouerd","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research (S.C.C., O.B., A.C., S.O., J.C.F.-A., T.B., P.P., E.L.S.), and Department of Medicine (E.L.S.), Sir Mortimer B. Davis\u2013Jewish General Hospital, McGill University, Montreal, Qu\u00e9bec, Canada; and Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse, Bad Nauheim, Germany (S.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falio C.","family":"Fraulob-Aquino","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research (S.C.C., O.B., A.C., S.O., J.C.F.-A., T.B., P.P., E.L.S.), and Department of Medicine (E.L.S.), Sir Mortimer B. Davis\u2013Jewish General Hospital, McGill University, Montreal, Qu\u00e9bec, Canada; and Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse, Bad Nauheim, Germany (S.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tlili","family":"Barhoumi","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research (S.C.C., O.B., A.C., S.O., J.C.F.-A., T.B., P.P., E.L.S.), and Department of Medicine (E.L.S.), Sir Mortimer B. Davis\u2013Jewish General Hospital, McGill University, Montreal, Qu\u00e9bec, Canada; and Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse, Bad Nauheim, Germany (S.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Offermanns","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research (S.C.C., O.B., A.C., S.O., J.C.F.-A., T.B., P.P., E.L.S.), and Department of Medicine (E.L.S.), Sir Mortimer B. Davis\u2013Jewish General Hospital, McGill University, Montreal, Qu\u00e9bec, Canada; and Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse, Bad Nauheim, Germany (S.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Paradis","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research (S.C.C., O.B., A.C., S.O., J.C.F.-A., T.B., P.P., E.L.S.), and Department of Medicine (E.L.S.), Sir Mortimer B. Davis\u2013Jewish General Hospital, McGill University, Montreal, Qu\u00e9bec, Canada; and Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse, Bad Nauheim, Germany (S.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto L.","family":"Schiffrin","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research (S.C.C., O.B., A.C., S.O., J.C.F.-A., T.B., P.P., E.L.S.), and Department of Medicine (E.L.S.), Sir Mortimer B. Davis\u2013Jewish General Hospital, McGill University, Montreal, Qu\u00e9bec, Canada; and Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse, Bad Nauheim, Germany (S.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/332411a0"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011833"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2005.03.004"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001183220315"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715010-00005"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803193381202"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02933-3"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61500-2"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.24.2.183"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.30.4.905"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.4.769"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199800001-00086"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.138701"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05168"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.187021"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx108"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.07802"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpw078"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-013-0413-9"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/27.22.4324"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082150"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.162941"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.11"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161212802002760"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.198770"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00162.2016"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2015.12.043"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1836"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000144462.08345.B9"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04456"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu119"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.181123"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.3652"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.02.026"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.10.1.1"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00060.2009"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2009.01.016"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34487"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1159\/000458737"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.306539"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.86"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127507"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008010009"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61766-8"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.117.09925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:09:38Z","timestamp":1715591378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.117.09925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.117.09925"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.117.09925","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"2017-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}